You’ve Already Paid $6 Billion For Weight-Loss Drugs You Can’t Afford
U.S. taxpayers spent billions developing Ozempic-type diabetes and weight-loss drugs — now those drugs’ markups could bankrupt the U.S. health care system.
Health Care
Deep dives into the political corruption and corporate bureaucracy that keeps Americans sick while making executives rich.
The Billion-Dollar Taxpayer Math Behind The Ozempic Boom
How Americans spent $6.2 billion to develop overpriced diabetes and weight-loss drugs.
The Hidden Cost Behind Your “$0 Copay” Drug Assistance Program
Copay assistance programs are supposed to reduce drug costs and cover patients’ deductibles — so why are so many people getting stuck with a bill?
YOU LOVE TO SEE IT: Whole Foods Workers Take On Bezos
Whole Foods workers are made whole, corporate criminals face the music, private equity loses its painkillers, and an empire of pain gets a taste of its own medicine.
The Deadly Secrets Behind “Breakthrough” Alzheimer’s Drugs
Regulators approved controversial therapies amid excess deaths, questionable efficacy, and conflicts of interest.
New Alzheimer’s Drugs Shrink Your Brain — Is That Bad?
Alzheimer’s Disease shrinks your brain — why do the new drugs for the condition do the same thing?
What Alzheimer’s Drugs Do Inside Your Skull
Drugmakers say small brain bleeds and swelling caused by the new Alzheimer’s drugs are benign and self-resolving — but are they?
Wall Street Is Jacking Up The Cost Of Your Doctor Visits
A groundbreaking study finds doctors affiliated with hospitals and private equity firms are charging billions more annually than independent general practitioners.
Drug Commercials Aren’t Just Annoying — They’re Costing You Money
While proponents claim direct-to-consumer drug ads educate consumers, critics say that mass-market misinformation is costing patients and taxpayers alike.
The McKinsey Opioid Consultants Who Got Away
The Biden administration just delivered a sweetheart deal to its friends at McKinsey, letting the consulting giant off the hook for helping to “turbocharge” disastrous OxyContin sales.